BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16413271)

  • 21. Differential membrane association properties and regulation of class I and class II Arfs.
    Duijsings D; Lanke KH; van Dooren SH; van Dommelen MM; Wetzels R; de Mattia F; Wessels E; van Kuppeveld FJ
    Traffic; 2009 Mar; 10(3):316-23. PubMed ID: 19170981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arf3 is activated uniquely at the trans-Golgi network by brefeldin A-inhibited guanine nucleotide exchange factors.
    Manolea F; Chun J; Chen DW; Clarke I; Summerfeldt N; Dacks JB; Melançon P
    Mol Biol Cell; 2010 Jun; 21(11):1836-49. PubMed ID: 20357002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific functions of BIG1 and BIG2 in endomembrane organization.
    Boal F; Stephens DJ
    PLoS One; 2010 Mar; 5(3):e9898. PubMed ID: 20360857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The small G protein Arl1 directs the trans-Golgi-specific targeting of the Arf1 exchange factors BIG1 and BIG2.
    Christis C; Munro S
    J Cell Biol; 2012 Feb; 196(3):327-35. PubMed ID: 22291037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Class II Arfs require a brefeldin-A-sensitive factor for Golgi association.
    Dejgaard SY; Presley JF
    Biochem Biophys Res Commun; 2020 Sep; 530(1):301-306. PubMed ID: 32828303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockout of Arfrp1 leads to disruption of ARF-like1 (ARL1) targeting to the trans-Golgi in mouse embryos and HeLa cells.
    Zahn C; Hommel A; Lu L; Hong W; Walther DJ; Florian S; Joost HG; Schürmann A
    Mol Membr Biol; 2006; 23(6):475-85. PubMed ID: 17127620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arf guanine nucleotide-exchange factors BIG1 and BIG2 regulate nonmuscle myosin IIA activity by anchoring myosin phosphatase complex.
    Le K; Li CC; Ye G; Moss J; Vaughan M
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):E3162-70. PubMed ID: 23918382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1.
    Wessels E; Duijsings D; Niu TK; Neumann S; Oorschot VM; de Lange F; Lanke KH; Klumperman J; Henke A; Jackson CL; Melchers WJ; van Kuppeveld FJ
    Dev Cell; 2006 Aug; 11(2):191-201. PubMed ID: 16890159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Arf activation: the Sec7 family of guanine nucleotide exchange factors.
    Casanova JE
    Traffic; 2007 Nov; 8(11):1476-85. PubMed ID: 17850229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein, is required for correct glycosylation and function of integrin beta1.
    Shen X; Hong MS; Moss J; Vaughan M
    Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1230-5. PubMed ID: 17227842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of class II ADP-ribosylation factors as cellular factors required for hepatitis C virus replication.
    Farhat R; Séron K; Ferlin J; Fénéant L; Belouzard S; Goueslain L; Jackson CL; Dubuisson J; Rouillé Y
    Cell Microbiol; 2016 Aug; 18(8):1121-33. PubMed ID: 26814617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of cellular Arf GTPases by poliovirus protein 3CD correlates with virus replication.
    Belov GA; Habbersett C; Franco D; Ehrenfeld E
    J Virol; 2007 Sep; 81(17):9259-67. PubMed ID: 17567696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brefeldin A-inhibited ADP-ribosylation factor activator BIG2 regulates cell migration via integrin β1 cycling and actin remodeling.
    Shen X; Li CC; Aponte AM; Shen RF; Billings EM; Moss J; Vaughan M
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14464-9. PubMed ID: 22908276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional diversification of closely related ARF-GEFs in protein secretion and recycling.
    Richter S; Geldner N; Schrader J; Wolters H; Stierhof YD; Rios G; Koncz C; Robinson DG; Jürgens G
    Nature; 2007 Jul; 448(7152):488-92. PubMed ID: 17653190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Arf1 GTPase mutant with different responses to GEF inhibitors.
    Flisiak S; Zeeh JC; Guibert B; Cherfils J; Zeghouf M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):156-60. PubMed ID: 18834864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assays and properties of arfaptin 2 binding to Rac1 and ADP-ribosylation factors (Arfs).
    Shin OH; Exton JH
    Methods Enzymol; 2005; 404():359-67. PubMed ID: 16413282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of recombinant human ADP-ribosylation factors by reversed-phase high-performance liquid chromatography and electrospray mass spectrometry.
    Berger SJ; Claude AC; Melançon P
    Anal Biochem; 1998 Nov; 264(1):53-65. PubMed ID: 9784188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GBF1, a cis-Golgi and VTCs-localized ARF-GEF, is implicated in ER-to-Golgi protein traffic.
    Zhao X; Claude A; Chun J; Shields DJ; Presley JF; Melançon P
    J Cell Sci; 2006 Sep; 119(Pt 18):3743-53. PubMed ID: 16926190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and anticancer activity of brefeldin A ester derivatives.
    Anadu NO; Davisson VJ; Cushman M
    J Med Chem; 2006 Jun; 49(13):3897-905. PubMed ID: 16789745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple and stepwise interactions between coatomer and ADP-ribosylation factor-1 (Arf1)-GTP.
    Sun Z; Anderl F; Fröhlich K; Zhao L; Hanke S; Brügger B; Wieland F; Béthune J
    Traffic; 2007 May; 8(5):582-93. PubMed ID: 17451557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.